Promethazine Hydrochloride

盐酸异丙嗪

Report date: 2023/02/23 20:00:33
NME

Base Information

Drug NamePromethazine Hydrochloride
Drug Alias Name异丙嗪盐酸盐Promethazinum氢氯化异丙嗪Prometazina盐酸普鲁米嗪 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsSedationVomitingNausea +[18] 
Global Approved IndicationsSedationNauseaMotion Sickness +[14] 
Approved Indications in ChinaSedationNauseaMotion Sickness +[5] 
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesEUMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWyeth Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMitsubishi Tanabe PharmaTianjin Lisheng Pharmaceutical Co Ltd
Inactive CompaniesSandozPharmobedient Consulting LLCCharleston Laboratories Inc +[4] 
Active IndicationsSedationNauseaMotion Sickness +[5] 
Inactive IndicationsVomitingPainPostoperative Nausea and Vomiting +[13] 

Other Information

ATC CodeD04AA10R06AD02
Related LinksWikipediaDrugBankKEGG